Pathogénie du syndrome néphrotique à lesions glomérulaires minimes. médecine/sciences, pp.853-861, 2008. ,
Physiopathology and treatment of nephrotic syndrome complications ,
URL : https://hal.archives-ouvertes.fr/inserm-00484814
Membranous Nephropathy and Thromboembolism: Is Prophylactic Anticoagulation Warranted?, Nephron, vol.63, issue.3, pp.249-54, 1993. ,
DOI : 10.1159/000187205
A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis, Bull Johns Hopkins Hosp, vol.100, issue.4, pp.173-86, 1957. ,
Pathologic classification of focal segmental glomerulosclerosis: a working proposal, American Journal of Kidney Diseases, vol.43, issue.2, pp.368-82, 2004. ,
DOI : 10.1053/j.ajkd.2003.10.024
Focal Segmental Glomerulosclerosis, New England Journal of Medicine, vol.365, issue.25, pp.2398-411, 2011. ,
DOI : 10.1056/NEJMra1106556
Syndromes n??phrotiques idiopathiques??: physiopathologie et prise en charge th??rapeutique sp??cifique chez l???adulte, N??phrologie & Th??rapeutique, vol.8, issue.3, pp.180-92, 2012. ,
DOI : 10.1016/j.nephro.2011.11.010
Genotype???phenotype analysis of pediatric patients with WT1 glomerulopathy, Pediatric Nephrology, vol.143, issue.Suppl 3, 2016. ,
DOI : 10.1007/s00467-016-3395-4
Molecular pathomechanisms of membranous nephropathy: from ,
Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients, Molecular Immunology, vol.68, issue.1, pp.57-62 ,
DOI : 10.1016/j.molimm.2015.07.003
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier, AJP: Renal Physiology, vol.296, issue.5, pp.947-56, 2009. ,
DOI : 10.1152/ajprenal.90601.2008
Hereditary Proteinuria Syndromes and Mechanisms of Proteinuria, New England Journal of Medicine, vol.354, issue.13, pp.1387-401, 2006. ,
DOI : 10.1056/NEJMra052131
Cell Biology of the Glomerular Podocyte, Physiological Reviews, vol.83, issue.1, pp.253-307, 2003. ,
DOI : 10.1152/physrev.00020.2002
What determines glomerular capillary permeability?, Journal of Clinical Investigation, vol.114, issue.10, 2004. ,
DOI : 10.1172/JCI23577
Fyn Binds to and Phosphorylates the Kidney Slit Diaphragm Component Nephrin, Journal of Biological Chemistry, vol.278, issue.23, pp.20716-20739, 2003. ,
DOI : 10.1074/jbc.M301689200
Src-Family Kinase Fyn Phosphorylates the Cytoplasmic Domain of Nephrin and Modulates Its Interaction with Podocin, Journal of the American Society of Nephrology, vol.15, issue.12, pp.3006-3021, 2004. ,
DOI : 10.1097/01.ASN.0000146689.88078.80
beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity, Proceedings of the National Academy of Sciences, vol.103, issue.38, pp.14110-14115, 2006. ,
DOI : 10.1073/pnas.0602587103
Nephrin and CD2AP Associate with Phosphoinositide 3-OH Kinase and Stimulate AKT-Dependent Signaling, Molecular and Cellular Biology, vol.23, issue.14, pp.4917-4945, 2003. ,
DOI : 10.1128/MCB.23.14.4917-4928.2003
Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes, Nature, vol.401, issue.7085, pp.818-841, 2006. ,
DOI : 10.1038/nature04662
Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization, Journal of Clinical Investigation, vol.116, issue.5, pp.1346-59, 2006. ,
DOI : 10.1172/JCI27414
Identification of Nck Family Genes, Chromosomal Localization, Expression, and Signaling Specificity, Journal of Biological Chemistry, vol.273, issue.39, pp.25171-25179, 1998. ,
DOI : 10.1074/jbc.273.39.25171
Role of the VEGF-A Signaling Pathway in the Glomerulus: Evidence for Crosstalk between Components of the Glomerular Filtration Barrier, Nephron Physiology, vol.106, issue.2 ,
DOI : 10.1159/000101798
Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy, Kidney International, vol.85, issue.2, pp.457-70, 2014. ,
DOI : 10.1038/ki.2013.344
URL : https://hal.archives-ouvertes.fr/inserm-00958760
Minimalchange glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation, pp.849-52, 1994. ,
Successful transplant of a kidney with focal segmental glomerulosclerosis, Nephrology Dialysis Transplantation, vol.16, issue.2, pp.416-423, 2001. ,
DOI : 10.1093/ndt/16.2.416
Resolution of Recurrent Focal Segmental Glomerulosclerosis after Retransplantation, New England Journal of Medicine, vol.366, issue.17, pp.1648-1657, 2012. ,
DOI : 10.1056/NEJMc1202500
Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis, Clin Nephrol, vol.48, issue.5, pp.282-289, 1997. ,
Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys, American Journal of Kidney Diseases, vol.32, issue.2, pp.230-237, 1998. ,
DOI : 10.1053/ajkd.1998.v32.pm9708606
New Insights into the Pathogenesis and the Therapy of Recurrent Focal Glomerulosclerosis, American Journal of Transplantation, vol.1, issue.6, pp.1179-85, 2005. ,
DOI : 10.1034/j.1600-6143.2002.21005.x
Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: Re-analysis of published case-reports and case-series, Journal of Clinical Apheresis, vol.46, issue.4, pp.175-183, 2001. ,
DOI : 10.1002/jca.10007
Transmission of Glomerular Permeability Factor from a Mother to Her Child, New England Journal of Medicine, vol.344, issue.5, pp.386-393, 2001. ,
DOI : 10.1056/NEJM200102013440517
Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation, Clin Nephrol, vol.22, issue.1, pp.32-40, 1984. ,
Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation, Feb, vol.1573, issue.3, pp.366-72, 2002. ,
A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome ,
Effect of Plasma Protein Adsorption on Protein Excretion in Kidney-Transplant Recipients with Recurrent Nephrotic Syndrome, New England Journal of Medicine, vol.330, issue.1, pp.7-14, 1994. ,
DOI : 10.1056/NEJM199401063300102
Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis, Kidney Research and Clinical Practice, vol.31, issue.4, pp.205-218, 2012. ,
DOI : 10.1016/j.krcp.2012.10.002
Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome, European Journal of Immunology, vol.343, issue.6, 1995. ,
DOI : 10.1002/eji.1830250604
Overexpression of Interleukin-13 Induces Minimal-Change-Like Nephropathy in Rats, Journal of the American Society of Nephrology, vol.18, issue.5, 2007. ,
DOI : 10.1681/ASN.2006070710
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance, Pediatric Nephrology, vol.27, issue.8, pp.1363-71, 2014. ,
DOI : 10.1007/s00467-013-2679-1
Hemopexin Induces Nephrin-Dependent Reorganization of the Actin Cytoskeleton in Podocytes, Journal of the American Society of Nephrology, vol.19, issue.11, pp.2140-2149, 2008. ,
DOI : 10.1681/ASN.2007080940
Circulating Permeability Factors in Primary Focal ,
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis, Nature Medicine, vol.119, issue.8, pp.952-60, 2011. ,
DOI : 10.1159/000093259
Circulating suPAR in Two Cohorts of Primary FSGS, Journal of the American Society of Nephrology, vol.23, issue.12, pp.2051-2060, 2012. ,
DOI : 10.1681/ASN.2012030302
Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer, Medicinal Research Reviews, vol.20, issue.1, pp.13-39, 2004. ,
DOI : 10.1002/med.10054
Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis, Clinical Journal of the American Society of Nephrology, vol.5, issue.11, 2010. ,
DOI : 10.2215/CJN.03800609
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation, Science Translational Medicine, vol.6, issue.256 ,
DOI : 10.1126/scitranslmed.3008538
PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTION, The Lancet, vol.304, issue.7880 ,
DOI : 10.1016/S0140-6736(74)91880-7
Recent approaches to the pathogenesis of minimal-change nephrotic syndrome, Nephrology Dialysis Transplantation, vol.18, issue.2, pp.245-253, 2003. ,
DOI : 10.1093/ndt/18.2.245
Regulatory T cells and minimal change nephropathy: in the midst of a complex network, Clinical & Experimental Immunology, vol.22, issue.2, pp.166-74, 2016. ,
DOI : 10.1111/cei.12675
A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening, J Am Soc Nephrol, vol.13, issue.5, pp.1238-1285, 2002. ,
Tc-mip), a New Proximal Signaling Protein, Induces c-maf Th2 Transcription Factor and Cytoskeleton Reorganization, J Exp Med, vol.198, issue.5, pp.797-807, 2003. ,
The Filamin-A is a partner of Tc-mip, a new adapter protein involved in c-maf-dependent Th2 signaling pathway, Molecular Immunology, vol.40, issue.17, pp.1257-61, 2004. ,
DOI : 10.1016/j.molimm.2003.11.035
C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity, Molecular Immunology, vol.46, issue.5, 2009. ,
DOI : 10.1016/j.molimm.2008.09.034
Paraneoplastic glomerulopathies: New insights into an old entity, Kidney International, vol.56, issue.1, pp.355-77, 1999. ,
DOI : 10.1046/j.1523-1755.1999.00548.x
Immune dysregulation in minimal change nephropathy, Nephrology Dialysis Transplantation, vol.18, issue.90006, pp.26-29, 2003. ,
DOI : 10.1093/ndt/gfg1066
Rituximab treatment for severe steroid-or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases, Pediatr Nephrol Berl Ger, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00453355
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis, Sci Transl Med, vol.3, issue.85, 2011. ,
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome, Nat Genet, vol.24, issue.4, pp.349-54, 2000. ,
The podocin mutation R229Q and early recurrence (within the first year) of glomerular disease after renal transplantation, Ann Transplant, vol.18, pp.436-478, 2013. ,
Mutations in ACTN4, encoding ??-actinin-4, cause familial
focal segmental glomerulosclerosis, Nature Genetics, vol.6, issue.3, pp.251-257, 2000. ,
DOI : 10.1038/7675
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function, Nature Genetics, vol.11, issue.7, pp.739-783, 2005. ,
DOI : 10.1006/jmbi.2000.4042
A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis, Science, vol.308, issue.5729 ,
DOI : 10.1126/science.1106215
Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation, Kidney International, vol.72, issue.10 ,
DOI : 10.1038/sj.ki.5002469
Motherto-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases, J ,
LMX1B Mutations Cause Hereditary FSGS without Extrarenal Involvement, Journal of the American Society of Nephrology, vol.24, issue.8, 2013. ,
DOI : 10.1681/ASN.2013020171
Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip ,
URL : https://hal.archives-ouvertes.fr/inserm-00485558
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis Kidney Disease : Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis, Am J Kidney Dis. Kidney Inter, vol.622, issue.83, pp.403-41139, 2012. ,
Controlled Trial of Prednisone in Adult Patients with the Nephrotic Syndrome, BMJ, vol.3, issue.5720, pp.421-427, 1970. ,
DOI : 10.1136/bmj.3.5720.421
Long-term outcome of adult-onset minimal-change nephropathy, Nephrology Dialysis Transplantation, vol.11, issue.11, pp.2192-201, 1996. ,
DOI : 10.1093/oxfordjournals.ndt.a027136
Treatment of idiopathic nephrosis by immunophillin modulation, Nephrology Dialysis Transplantation, vol.18, issue.90006, pp.79-86, 2003. ,
DOI : 10.1093/ndt/gfg1067
Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome, Nephrology Dialysis Transplantation, vol.25, issue.1, pp.124-133, 2010. ,
DOI : 10.1093/ndt/gfp422
The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea, Clin Nephrol, vol.43, issue.6, pp.375-81, 1995. ,
Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis, Clin Nephrol, vol.44, issue.3, pp.156-62, 1995. ,
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis, Kidney International, vol.56, issue.6, 1999. ,
DOI : 10.1046/j.1523-1755.1999.00778.x
Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis, American Journal of Kidney Diseases, vol.43, issue.1, pp.10-18, 2004. ,
DOI : 10.1053/j.ajkd.2003.09.027
Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome, Nephrology Dialysis Transplantation, vol.17, issue.11, pp.2011-2014, 2002. ,
DOI : 10.1093/ndt/17.11.2011
Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome, Clinical Nephrology, vol.65, issue.06, pp.393-400, 2006. ,
DOI : 10.5414/CNP65393
Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up, Nephrology Dialysis Transplantation, vol.17, issue.4, pp.655-62, 2002. ,
DOI : 10.1093/ndt/17.4.655
Tacrolimus Therapy in Adults With Steroid- and Cyclophosphamide-Resistant Nephrotic Syndrome and Normal or Mildly Reduced GFR, American Journal of Kidney Diseases, vol.54, issue.1, pp.51-59, 2009. ,
DOI : 10.1053/j.ajkd.2009.02.018
Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance, Nephrology Dialysis Transplantation, vol.29, issue.11, pp.2084-91, 2014. ,
DOI : 10.1093/ndt/gfu209
Rituximab therapy in nephrotic syndrome: implications for patients' management, Nature Reviews Nephrology, vol.25, issue.3, pp.154-69 ,
DOI : 10.1038/nrneph.2012.289
Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease, Kidney International, vol.83, issue.3 ,
DOI : 10.1038/ki.2012.444
URL : https://hal.archives-ouvertes.fr/inserm-00919110
Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment, Medicine, vol.93, issue.29, p.300, 2014. ,
DOI : 10.1097/MD.0000000000000300
A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood, BMC Research Notes, vol.24, issue.1, 2015. ,
DOI : 10.1186/s13104-015-1255-0
Treatment Strategies of Adult Primary Focal 94 ,
Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy, Clinical Nephrology, vol.65, issue.06, pp.423-429, 2006. ,
DOI : 10.5414/CNP65423
LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy, Clin Nephrol, vol.50, issue.1, pp.1-7, 1998. ,
Significantly Rapid Relief from Steroid-Resistant Nephrotic Syndrome by LDL Apheresis Compared with Steroid Monotherapy, Nephron, vol.89, issue.4, pp.408-423, 2001. ,
DOI : 10.1159/000046112
Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease, Clinical Nephrology, vol.80, issue.08, pp.121-130, 2013. ,
DOI : 10.5414/CN107723
Treatment of Idiopathic FSGS with Adrenocorticotropic Hormone Gel, Clinical Journal of the American Society of Nephrology, vol.8, issue.12, pp.2072-81, 2013. ,
DOI : 10.2215/CJN.02840313
Followup of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group, BMC Nephrol, vol.11, issue.2, 2010. ,
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group, BMC Nephrology, vol.66, issue.8 Suppl, 2015. ,
DOI : 10.1016/j.jclinepi.2013.04.006
Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.5, issue.11, 2013. ,
DOI : 10.1007/s00467-013-2539-z
Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte, Clinical Science, vol.126, issue.12, pp.883-93, 1979. ,
DOI : 10.1152/ajprenal.00161.2010
Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals, Journal of the American Society of Nephrology, vol.27, issue.5 ,
DOI : 10.1681/ASN.2015040373
Cancer in ESRD: Clear on the Epidemiology, Hazy on the Mechanisms, Journal of the American Society of Nephrology, vol.27, issue.5, pp.1272-1277, 2016. ,
DOI : 10.1681/ASN.2015091021
Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease, Medicine, vol.95, issue.12, p.3179, 2016. ,
DOI : 10.1097/MD.0000000000003179
Recurrent focal glomerulosclerosis: Natural history and response to therapy, The American Journal of Medicine, vol.92, issue.4, pp.375-83, 1992. ,
DOI : 10.1016/0002-9343(92)90267-F
Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection, Kidney International, vol.45, issue.5, pp.1440-1445, 1994. ,
DOI : 10.1038/ki.1994.188
Graft Loss Due to Recurrent Focal Segmental Glomerulosclerosis in Renal Transplant Recipients in the United States, American Journal of Kidney Diseases, vol.37, issue.2, pp.366-73, 2001. ,
DOI : 10.1053/ajkd.2001.21311
Renal Allograft Survival in Transplant Recipients with Focal Segmental Glomerulosclerosis, American Journal of Transplantation, vol.71, issue.1, pp.64-71, 2003. ,
DOI : 10.1046/j.1523-1755.2001.00494.x
Glomerulonephritis recurrence in the renal graft, J Am Soc Nephrol, 2001. ,
Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS), Nephrology Dialysis Transplantation, vol.25, issue.4, pp.1321-1329, 2010. ,
DOI : 10.1093/ndt/gfp500
Extracorporeal plasma treatment in primary and recurrent focal 96 ,
Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation, Transplant International, vol.75, issue.3, pp.151-158, 2004. ,
DOI : 10.1093/ndt/15.1.78
Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients, Transplantation Reviews, vol.24, issue.3, pp.121-129, 2010. ,
DOI : 10.1016/j.trre.2010.04.001
Monoclonal antibodies for podocytopathies: rationale and clinical responses, Nature Reviews Nephrology, vol.216, issue.6, pp.337-385, 2009. ,
DOI : 10.1038/nrneph.2009.70
Adult???onset minimal change nephrotic syndrome: A long???term follow???up, Kidney International, vol.29, issue.6, 1986. ,
DOI : 10.1038/ki.1986.130
Minimal-Change Nephrotic Syndrome in Adults Treated with Alternate-Day Steroids, Nephron, vol.47, issue.3, pp.209-219, 1987. ,
DOI : 10.1159/000184494
Minimal-Change Glomerulopathy of Adulthood, American Journal of Nephrology, vol.8, issue.4 ,
DOI : 10.1159/000167603
Minimal Change Nephrotic Syndrome in Adults: Response to Corticosteroid Therapy and Frequency of Relapse, American Journal of Kidney Diseases, vol.17, issue.6 ,
DOI : 10.1016/S0272-6386(12)80353-2
Adult-Onset Minimal Change Disease among Taiwanese, American Journal of Nephrology, vol.21, issue.1, pp.28-34, 2001. ,
DOI : 10.1159/000046215
Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome, American Journal of Kidney Diseases, vol.39, issue.3 ,
DOI : 10.1053/ajkd.2002.31400
Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses, Nephrology Dialysis Transplantation, vol.18, issue.7 ,
DOI : 10.1093/ndt/gfg134
Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study, Clinical and Experimental Nephrology, vol.50, issue.11, 2013. ,
DOI : 10.1007/s10157-013-0793-9
Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis, Clinical Kidney Journal, vol.9, issue.3, pp.381-387 ,
DOI : 10.1093/ckj/sfw028
The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine (Baltimore), pp.304-315, 1986. ,
The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults ,
Primary Focal Segmental Glomerulosclerosis: Clinical Course and Response to Therapy, American Journal of Kidney Diseases, vol.23, issue.6, pp.773-83, 1994. ,
DOI : 10.1016/S0272-6386(12)80128-4
Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment, American Journal of Kidney Diseases, vol.25, issue.4, pp.534-576, 1995. ,
DOI : 10.1016/0272-6386(95)90120-5
Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis, Nephrology Dialysis Transplantation, vol.15, issue.9, pp.1348-56, 2000. ,
DOI : 10.1093/ndt/15.9.1348
Focal and Segmental Glomerulosclerosis: Definition and Relevance of a Partial Remission, Journal of the American Society of Nephrology, vol.16, issue.4, pp.1061-1069, 2005. ,
DOI : 10.1681/ASN.2004070593
Prognostic value of clinical, laboratory, and morphological factors in patients with primary focal segmental glomerulosclerosis -distribution of pathological variants in the Croatian population, Med Sci Monit, vol.15, issue.10, pp.121-129, 2009. ,
Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults, Nephrology Dialysis Transplantation, vol.27, issue.3, pp.1101-1107, 2012. ,
DOI : 10.1093/ndt/gfr430
Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients, BMC Nephrology, vol.26, issue.7 ,
DOI : 10.1093/ndt/gfq668
Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults, Nephrology, 2016. ,
DOI : 10.1111/nep.12816
Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis, The American Journal of Medicine, vol.82, issue.5, pp.938-982, 1987. ,
DOI : 10.1016/0002-9343(87)90155-0
Clinical picture and outcome of primary focal segmental glomerulosclerosis, Nephrology Dialysis Transplantation, vol.14, issue.90003, pp.68-73, 1999. ,
DOI : 10.1093/ndt/14.suppl_3.68
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease, New England Journal of Medicine, vol.330, issue.13, pp.877-84, 1994. ,
DOI : 10.1056/NEJM199403313301301
Genetic forms of nephrotic syndrome, Pediatric Nephrology, vol.13, issue.12, 2004. ,
DOI : 10.1007/s00467-004-1676-9
Primary glomerular diseases in the elderly, World Journal of Nephrology, vol.4, issue.2, pp.263-70, 2015. ,
DOI : 10.5527/wjn.v4.i2.263
Idiopathic membranous nephropathy in the elderly, Nephrol Dial Transplant, vol.8, issue.12, pp.1321-1326, 1993. ,
Idiopathic membranous nephropathy in the elderly: A comparative study, American Journal of Kidney Diseases, vol.29, issue.2, pp.200-206, 1997. ,
DOI : 10.1016/S0272-6386(97)90030-5
A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.320, issue.1, pp.8-13, 1989. ,
DOI : 10.1056/NEJM198901053200102
Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine, International Urology and Nephrology, vol.46, issue.5, pp.131-136 ,
DOI : 10.1007/s11255-014-0850-7
Thrombus formation and plateletvessel wall interaction in the nephrotic syndrome under flow conditions, J Clin Invest, 1994. ,
Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome, The American Journal of Medicine, vol.65, issue.4, pp.607-620, 1978. ,
DOI : 10.1016/0002-9343(78)90848-3
Clinical correlation between hypercoagulability and thrombo-embolic phenomena, Kidney International, vol.31, issue.3, pp.830-835, 1987. ,
DOI : 10.1038/ki.1987.73
Coagulation Factors in Nephrotic Syndrome, American Journal of Nephrology, vol.10, issue.1, pp.63-71, 1990. ,
DOI : 10.1159/000168196
Kidney Disease and Death From Cancer, American Journal of Kidney Diseases, vol.63, issue.1, pp.7-9, 2014. ,
DOI : 10.1053/j.ajkd.2013.10.003
Onco-Nephrology: Core Curriculum 2015, American Journal of Kidney Diseases, vol.66, issue.5, pp.869-83, 2015. ,
DOI : 10.1053/j.ajkd.2015.04.042
Focal Segmental Glomerulosclerosis in Nephrotic Adults: Presentation, Prognosis, and Response to Therapy of the Histologic Variants, Journal of the American Society of Nephrology, vol.15, issue.8, pp.2169-77, 2004. ,
DOI : 10.1097/01.ASN.0000135051.62500.97
Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS, Clinical Journal of the American Society of Nephrology, vol.11, issue.3, pp.386-94, 2016. ,
DOI : 10.2215/CJN.07110615
Hyperglycemia related to highdose glucocorticoid use in noncritically ill patients, Diabetol Metab Syndr, vol.5, p.18, 2013. ,
Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review, World Journal of Diabetes, vol.6, issue.8, pp.1073-81, 2015. ,
DOI : 10.4239/wjd.v6.i8.1073
New-onset diabetes mellitus after renal transplantation, Biomedical Papers, vol.160, issue.2, 2016. ,
DOI : 10.5507/bp.2016.005
Early Pulse Pressure and Low-Grade Proteinuria as Independent Long-Term Risk Factors for New-Onset Diabetes Mellitus After Kidney Transplantation, American Journal of Transplantation, vol.72, issue.8, pp.1719-1747, 2008. ,
DOI : 10.1111/j.1600-6143.2008.02308.x
Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal Transplantation, Journal of the American Society of Nephrology, vol.23, issue.4, pp.739-788 ,
DOI : 10.1681/ASN.2011080835
Risk of Infectious Complications in Patients Taking Glucocorticosteroids, Clinical Infectious Diseases, vol.11, issue.6, pp.954-63, 1989. ,
DOI : 10.1093/clinids/11.6.954
Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis, Kidney International, vol.78, issue.3, pp.296-302, 2010. ,
DOI : 10.1038/ki.2010.143